Literature DB >> 12678881

Central amylin signaling and the regulation of energy homeostasis.

Paul A Rushing1.   

Abstract

Amylin is a 37-amino acid peptide hormone that is co-secreted with insulin by pancreatic B cells in response to food intake. Exogenous amylin potently and dose-dependently reduces feeding in rats and mice, with both central and peripheral sites being effective. Although amylin has been characterized as a satiety signal that regulates short-term food intake (i.e., meal size), recent data indicate that amylin may have long term effects on food intake and body weight. In fact, amylin shares many properties with the established adiposity signals, leptin and insulin. Like leptin and insulin, amylin is not synthesized within the brain, but is rapidly and efficiently transported across the blood-brain barrier (BBB) to a variety of discrete brain regions, including the hypothalamus, where populations of amylin binding sites are found. Further, amylin secretion and plasma levels are correlated with the degree of body adiposity, as is the case for leptin and insulin. In the following brief review, a summary of the findings from recent reports is presented supporting the hypothesis that amylin's role in the control of food intake is not limited to that of purely a satiety signal that brings individual bouts of ingestion to an end, but also serves as an adiposity signal acting within the brain to regulate long-term energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678881     DOI: 10.2174/1381612033455387

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Amylin peptide levels are raised in infants of diabetic mothers.

Authors:  V Kairamkonda; A Deorukhkar; R Coombs; R Fraser; T Mayer
Journal:  Arch Dis Child       Date:  2005-09-20       Impact factor: 3.791

2.  Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling.

Authors:  David J Reiner; Elizabeth G Mietlicki-Baase; Diana R Olivos; Lauren E McGrath; Derek J Zimmer; Kieran Koch-Laskowski; Joanna Krawczyk; Christopher A Turner; Emily E Noble; Joel D Hahn; Heath D Schmidt; Scott E Kanoski; Matthew R Hayes
Journal:  Biol Psychiatry       Date:  2017-01-10       Impact factor: 13.382

3.  Central amylin acts as an adiposity signal to control body weight and energy expenditure.

Authors:  Peter Y Wielinga; Christian Löwenstein; Sabine Muff; Manuela Munz; Stephen C Woods; Thomas A Lutz
Journal:  Physiol Behav       Date:  2010-04-21

Review 4.  Pramlintide for the treatment of insulin-requiring diabetes mellitus: rationale and review of clinical data.

Authors:  Davida F Kruger; Maurice A Gloster
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  The Melanin-Concentrating Hormone as an Integrative Peptide Driving Motivated Behaviors.

Authors:  Giovanne B Diniz; Jackson C Bittencourt
Journal:  Front Syst Neurosci       Date:  2017-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.